Talkiatry Named #6 on 2024 CB Insights’ 50 Most Innovative Digital Health Startups

Talkiatry recognized for achievements in behavioral health care

NEW YORK, Dec. 30, 2024 /PRNewswire/ — CB Insights today named Talkiatry as its sixth most promising organization on its 2024 Digital Health 50 — a list of the world’s 50 most promising private digital health companies, selected based on a combination of data signals and proprietary scoring.

“This year’s winners are at the forefront of bringing an AI-driven infrastructure to healthcare, transforming diagnostics, and bringing condition-specific care platforms to patients and providers. These companies are accelerating the transformation of healthcare delivery, streamlining workflows, and advancing patient outcomes globally. The 2024 Digital Health 50 cohort highlights high-momentum companies driving meaningful change across healthcare,” said Amrit Panjabi, Intelligence Analyst at CB Insights.

“Being named to CB Insights’ 2024 Digital Health 50 list highlights our leadership in telepsychiatry as well as our commitment to expanding access to high-quality mental healthcare solutions,” said Robert Krayn, co-founder and CEO of Talkiatry. “By integrating our value-based care model with a team of full-time, licensed physicians, Talkiatry improves health outcomes while reducing costs for patients, payors, and providers.”

From a pool of 10,000+ digital health startups, CB Insights analyzed companies using its proprietary metrics — Commercial Maturity and Mosaic scores — along with additional data on partnerships, funding, patents, leadership, and headcount. CB Insights supplemented this analysis with direct company submissions via Analyst Briefings.

Talkiatry is a leading telepsychiatry provider connecting patients with high-quality care that’s covered by insurance. In 2024, the company surpassed 1.5 million patient visits, expanded to 44 states, and continued building new in-network partnerships with insurers. Treatment with Talkiatry is now covered in more than 60 major health plans. Talkiatry has launched a number of new innovative partnerships and services that reach underserved populations, including mothers experiencing postpartum depression and seniors with mental health challenges. Its scalable value-based care model tackles pressing challenges by improving outcomes and reducing the total cost of care. Through technology and strategic collaborations, Talkiatry continues to set new standards for accessible and effective mental health care nationwide.

Quick facts on the 2024 Digital Health 50:

  • $3.5B in equity funding raised over time, including more than $1.5B in 2024 so far (as of 11/14/2024)
  • 72% of winners are building AI products, addressing everything from drug development to treatment selection to clinical documentation
  • 56% of winners are early-stage companies (seed or Series A)
  • Winners from 9 countries across the globe: the United States, Germany, Canada, Israel, South Korea, the United Kingdom, New Zealand, Belgium, and France
  • 200+ business relationships since 2022, including with industry leaders like Nvidia and Kaiser Permanente

About CB Insights

CB Insights is an AI super analyst for market intelligence. It delivers instant insights that help you bet on the right markets, track competitors, and source the right companies. This AI super analyst is powerful because it is built on the validated database of companies and markets that CB Insights is famous for. To learn more, please visit www.cbinsights.com.

Contact:
Media@cbinsights.com

About Talkiatry
Talkiatry is a national mental health practice that provides in-network psychiatry and therapy. They were co-founded by a patient and a triple-board-certified psychiatrist to solve the problems both groups face in accessing and providing the highest quality mental healthcare. 60% of adults in the U.S. with a diagnosable mental illness go untreated every year because care is inaccessible, while 45% of clinicians are out of network with insurers because reimbursement rates are low and paperwork is unduly burdensome. With innovative technology and a human-centered philosophy, Talkiatry provides patients with the care they need—and allows psychiatrists to focus on why they got into medicine. Learn more at www.talkiatry.com and follow us on Instagram, TikTok, and LinkedIn.

CONTACT:  Mark Karges, talkiatry@hermespr.co

View original content to download multimedia:https://www.prnewswire.com/news-releases/talkiatry-named-6-on-2024-cb-insights-50-most-innovative-digital-health-startups-302340348.html

SOURCE Talkiatry

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

15 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

15 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago